SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance
Leveraging the strengths of each partner to create synergies and expand the customer base
SBC Medical Group Holdings Incorporated (Nasdaq: SBC) (“SBC Medical”, or the “Company”, or “SBC”), a global owner, operator and provider of management services and products to cosmetic treatment centers, today announced a business alliance with MEDIROM Healthcare Technologies Inc. (Nasdaq: MRM) ("MEDIROM"), a rapidly growing company in the healthcare technology field with over 300 relaxation studios in Japan.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241103701498/en/

SBC Medical Group Holdings Incorporated, a global owner, operator and provider of management services and products to cosmetic treatment centers, today announced a business alliance with MEDIROM Healthcare Technologies Inc., a rapidly growing company in the healthcare technology field. (Graphic: Business Wire)
SBC Medical and MEDIROM, two trusted beauty and wellness leaders that excel in customer-centric experiences, together will create a new way for beauty and wellness enthusiasts to discover exciting and new health treatments. The alliance brings together MEDIROM’s leading brand of relaxation salons and health-related product and service offerings with SBC’s best-in-class cosmetic treatment centers that today serve millions of customers who love the ease, convenience, and value of SBC’s experience.
Together, the two leading healthcare service providers have more than 4 million members across their loyalty programs at SBC’s “Shonan Beauty Clinic” and MEDIROM’s Re.Ra.Ku. In addition to bringing customers enhanced offerings and expertise, the alliance will seek to create compelling, integrated opportunities to harness the power of these loyal customers and reward them when they receive services at SBC Medical and MEDIROM.
Background of Alliance
Based on the concept of " Ultimate Win-Win for All " SBC Medical Group provides management support services to a wide range of medical institutions, including comprehensive cosmetic medicine, dentistry, AGA treatment, gynecology, infertility treatment, ophthalmology, plastic surgery, and regenerative medicine. The Company’s network of clinics, including “Shoan Beauty Clinic”, now numbers 224 worldwide. MEDIROM, under the brand name “Re.Ra.Ku”, operates more than 300 relaxation studios in Japan based on the concept of "health, more, and more innovative," and is developing a diversified business centered on healthcare. The company also focuses on health maintenance and preventive medicine, and continues to innovate in this industry.
Reaching new customers and creation of synergies
In this alliance, both companies have elevated expectations for their different customer segments. Shonan Beauty Clinic is widely supported mainly by women in their 20s and 30s, while MEDIROM's Re.Ra.Ku serves mainly male customers for relaxation and health maintenance. This collaboration is expected to enable the two companies to approach new markets, expand our total customer base, and provide new value. As a first step, during the period from November 15, 2024 to December 15, 2024, customers visiting Shonan Beauty Clinic will receive special invitation tickets to experience Re.Ra.Ku at a discounted price. The two companies plan to continue to deepen their collaboration in stages, aiming to provide new value oriented experiences that offer total support for beauty and health.
Initial Co-Marketing Campaign
Customers visiting Shonan Beauty Clinic and Re.Ra.Ku will receive special invitation tickets for a limited time.
Participating Clinics and Stores
Shonan Beauty Clinic: 130 clinics
Re.Ra.Ku (directly managed stores): 230 stores
Distribution period
Shonan Beauty Clinic: Friday, November 15, 2024 - Sunday, December 15, 2024
Re.Ra.Ku: Sunday, December 1, 2024 - Monday, January 13, 2025
About MEDIROM Healthcare Technologies Inc.
MEDIROM Healthcare Technologies Inc., together with its subsidiaries, provides holistic health services in Japan. It operates in three segments: Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty. The Relaxation Salon segment owns, develops, operates, franchises, and supports relaxation salons, which provide finger-pressure style bodywork therapy, stretch therapy, and posture and joint alignment, as well as physical therapy elements; and various individual services, including anti-fatigue therapy, athletic support therapy, slim-down therapy, and reflexology.
About SBC Medical
SBC Medical, through its subsidiaries, provides services to support the operation of clinics that deliver highly specialized medical services in the areas of cosmetic medicine, esthetic dentistry, and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand. SBC Medical and its subsidiaries now provide management services to a total of 224 franchisees located worldwide. For Global, SBC Medical owns and operates one treatment center in Vietnam and provides management services to one treatment center in State of California in the United States. For more information, visit https://sbc-holdings.com/
Forward Looking Statements
This press release contains forward-looking statements. In addition, from time to time, we or our representatives may make forward-looking statements orally or in writing. We base these forward-looking statements on our expectations and projections about future events, which we derive from the information currently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. Factors that may cause actual results to differ materially from current expectations include, among other things, those listed under the heading “Risk Factors” and elsewhere in the proxy statement and other materials filed with the U.S. Securities and Exchange Commission. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We are not obligated to publicly update or revise any forward-looking statement, whether because of uncertainties and assumptions, the forward-looking events discussed in this press release and other statements made from time to time by us or our representatives might not occur. Past performance is not indicative of future results. There is no guarantee that any specific outcome will be achieved. Investments may be speculative, illiquid and there is a total risk of loss.
View source version on businesswire.com: https://www.businesswire.com/news/home/20241103701498/en/

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Suzano Reports Record First-Quarter Revenue9.5.2025 02:12:00 CEST | Press release
Suzano, the world’s largest pulp producer, announces its first quarter results for 2025 (1Q25) with record net revenue of R$11.6 billion, up 22% on the same quarter last year (1Q24). The result was driven by the exchange rates, increased pulp sales volumes from the new Ribas do Rio Pardo mill, higher paper volume and prices and the positive contribution from our paperboard mills recently acquired in the U.S. The record revenues occurred despite a series of planned downtimes in the quarter, including production lines of the Três Lagoas Unit, Mucuri Unit, and Aracruz Unit, and the Ribas do Rio Pardo Unit’s first scheduled maintenance downtime. Sales exceeded 3 million tonnes in the quarter, a rise of 12% compared to 1Q24, comprising 2.7 million tonnes of pulp and 390 thousand tonnes of paper, up 10% and 25%, respectively, on the same quarter last year. Adjusted EBITDA totaled R$4.9 billion, a 7% increase over 1Q24. Operating cash generation totaled R$2.6 billion, rising 5% on 1Q24. Net p
Andersen Consulting udvider platformen i Asien og Stillehavsområdet med tilføjelsen af Sertis8.5.2025 23:13:00 CEST | Pressemeddelelse
Andersen Consulting udvider sin dækning i Thailand og Indonesien med sin nyeste medlemsvirksomhed, Sertis, et førende konsulentfirma, der leverer datadrevne AI-løsninger til virksomheder i og uden for Sydøstasien. Dette strategiske skridt styrker Andersen Consultings tilstedeværelse i regionen og styrker organisationens kompetencer inden for AI-området. Sertis blev grundlagt i 2014 af Tee Vachiramon og har specialiseret sig i konsulenttjenester inden for AI og teknologitransformation, herunder udvikling af AI-strategi, tilpassede AI-løsninger, dataanalyse og digital omstilling. Firmaet arbejder med kunder i forskellige sektorer, herunder finans, detailhandel, energi, sundhedspleje og produktion, og sætter dem i stand til at optimere driften, træffe bedre beslutninger og forbedre kundeoplevelsen. "At blive medlem af Andersen Consulting er en milepæl for vores firma, da det giver os mulighed for at trække på en enestående platform med brancheførende løsninger til vores kunder," siger Tee
GC Aesthetics® Strengthens Board of Directors with Strategic Appointments8.5.2025 17:10:00 CEST | Press release
GC Aesthetics® (GCA), a privately-held medical technology company providing aesthetic and reconstruction solutions for global healthcare markets is pleased to announce the appointment of Mr. Luigi Ferrari as Chairman of the Board (non-executive) and Mr. Patrick Lee as Board Director, reinforcing the company’s strategic direction and long-term growth plans. These appointments follow the renewed phase of partnership initiated in early 2024 with Hayfin Capital Management, a longstanding investor in GCA. This collaboration has brought fresh momentum to the company’s commitment to innovation, safety, and global expansion in aesthetic and reconstructive breast surgery. Luigi Ferrari, a seasoned executive and investor with a proven track record in the healthcare sector, brings deep leadership experience, commercial growth expertise and industry insight. From 2012 to 2022 he was CEO of Lima Corporate, a global medical device company in the joint replacement market, acquired then by Enovis Corp
PPG to invest $380 million to buildnew U.S. manufacturing facility in Shelby, N.C. for aerospace coatings and sealants8.5.2025 16:30:00 CEST | Press release
PPG (NYSE: PPG) today announced that it will invest $380 million to build a new aerospace coatings and sealants manufacturing facility in Shelby, N.C. Construction on the 62-acre site, which will initially include manufacturing and warehousing units, is set to commence in October 2025 and is expected to be completed in the first half of 2027. The 198,000-square-foot facility will enable the company to continue meeting the growing demands of the aerospace industry. It will employ more than 110 people and produce the full line of PPG’s aerospace coatings and sealants. The additional capacity of this new plant, combined with nearby transport links that improve supply chain and shipping logistics, will help improve service levels for customers. “PPG’s investment in this new manufacturing facility demonstrates the significant demand growth for our world-class technologies and our continued commitment to serving our aerospace customers,” said Tim Knavish, PPG chairman and chief executive off
WHOOP Unveils WHOOP® 5.0 and WHOOP® MG: Powerful New Devices with Breakthrough Health and Longevity Features8.5.2025 16:00:00 CEST | Press release
Three New Membership Tiers Introduced to Make the Most Advanced Wearable More Accessible and PersonalizedView the WHOOP Launch Announcement here. WHOOP, the human performance company, today introduces WHOOP 5.0 and WHOOP MG — two next-generation wearables designed to unlock a new approach to personal health and longevity. Paired with a redesigned WHOOP experience, the devices offer 14-day battery life in a sleeker, seven percent smaller form - and introduce category-defining features, including Healthspan with WHOOP Age, Heart Screener with on-demand ECG, Blood Pressure Insights, and more. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250508546933/en/ WHOOP Unveils Next Generation WHOOP® 5.0 and WHOOP® MG These innovations arrive at a pivotal moment when ailing health systems cost more and deliver less. WHOOP is advancing a new solution and a better way - one that empowers people to connect their daily decisions to performa
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom